Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 1/20 | 0.66 |
| ▸ | CCR1 | P32246 | 2/20 | 0.43 |
| ▸ | CCR5 | P51681 | 2/20 | 0.43 |
| ▸ | CCR8 | P51685 | 2/20 | 0.43 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.40 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.40 |
| ▸ | NOS3 | P29474 | 1/20 | 0.38 |
| ▸ | NOS1 | P29475 | 1/20 | 0.38 |
| ▸ | NOS2 | P35228 | 1/20 | 0.38 |
| ▸ | USP8 | P40818 | 1/20 | 0.37 |
| ▸ | USP7 | Q93009 | 1/20 | 0.37 |
| ▸ | MAOB | P27338 | 2/20 | 0.37 |
| ▸ | MAOA | P21397 | 1/20 | 0.37 |
| ▸ | ELANE | P08246 | 1/20 | 0.35 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | TOP2A | P11388 | 1/20 | 0.34 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.34 |
| ▸ | RAB9A | P51151 | 2/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12108751 | 0.91 | KMT2A (0.66) | KMT2ACCR1CCR5CCR8PTGS1 | |
| SCHEMBL13151876 | 0.91 | KMT2A (0.71) | KMT2ACCR1CCR5CCR8PTGS1 | |
| SCHEMBL8917379 | 0.88 | KMT2A (0.86) | KMT2AMAOBELANEPDK2RAB9A | |
| SCHEMBL12110126 | 0.87 | KMT2A (0.67) | KMT2ACCR1CCR5CCR8PTGS1 | |
| SCHEMBL17339870 | 0.85 | KMT2A (0.51) | KMT2ACCR1CCR5CCR8PTGS1 | |
| SCHEMBL12760700 | 0.80 | KMT2A (0.50) | KMT2ACCR1CCR5CCR8PTGS1 | |
| SCHEMBL13168840 | 0.80 | KMT2A (0.54) | KMT2ACCR1CCR5CCR8PTGS1 | |
| SCHEMBL13940472 | 0.80 | KMT2A (0.68) | KMT2ACCR1CCR5CCR8PTGS1 | |
| SCHEMBL13168841 | 0.79 | KMT2A (0.49) | KMT2ACCR1CCR5CCR8PTGS1 | |
| SCHEMBL6597313 | 0.79 | KMT2A (0.49) | KMT2ACCR1CCR5CCR8PTGS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1080090-B1 | ANTITUMOUR 1,5-DIAZAANTHRAQUINONES | UNIV MADRID COMPLUTENSE (ES) | 2004-02-25 | — | — | EP | claimed |
| US-6525063-B2 | 3,7-dimethyl-1,5-diazaanthraquinone for example | UNIVERSIDAD COMPLUTENSE DE MADRID (ES) | 2003-02-25 | — | — | US | claimed |
| US-20020099066-A1 | Antitumour 1,5-diazaanthraquinones | UNIVERSIDAD COMPLUTENSE DE MADRID (ES) | 2002-07-25 | — | — | US | claimed |
| US-9214634-B2 | Organic photovoltaic cell, organic semiconductor polymer and composition for organic semiconductor material used therefor | FUJIFILM CORPORATION (JP) | 2015-12-15 | — | — | US | disclosed |
| US-9214634-B2 | Organic photovoltaic cell, organic semiconductor polymer and composition for organic semiconductor material used therefor | FUJIFILM CORPORATION (JP) | 2015-12-15 | — | — | US | disclosed |
| US-8465889-B2 | Electrophotographic photosensitive member, process cartridge, and electrophotographic apparatus | CANON KABUSHIKI KAISHA (JP) | 2013-06-18 | — | — | US | disclosed |
| US-8465889-B2 | Electrophotographic photosensitive member, process cartridge, and electrophotographic apparatus | CANON KABUSHIKI KAISHA (JP) | 2013-06-18 | — | — | US | disclosed |
| US-8435706-B2 | — | — | 2013-05-07 | — | — | US | disclosed |
| US-8435706-B2 | — | — | 2013-05-07 | — | — | US | disclosed |
| US-20110268472-A1 | ELECTROPHOTOGRAPHIC PHOTOSENSITIVE MEMBER, PROCESS CARTRIDGE, AND ELECTROPHOTOGRAPHIC APPARATUS | CANON KABUSHIKI KAISHA (JP) | 2011-11-03 | — | — | US | disclosed |
| US-20110268472-A1 | ELECTROPHOTOGRAPHIC PHOTOSENSITIVE MEMBER, PROCESS CARTRIDGE, AND ELECTROPHOTOGRAPHIC APPARATUS | CANON KABUSHIKI KAISHA (JP) | 2011-11-03 | — | — | US | disclosed |
| EP-1080090-B1 | ANTITUMOUR 1,5-DIAZAANTHRAQUINONES | UNIV MADRID COMPLUTENSE (ES) | 2004-02-25 | — | — | EP | disclosed |
| US-6525063-B2 | 3,7-dimethyl-1,5-diazaanthraquinone for example | UNIVERSIDAD COMPLUTENSE DE MADRID (ES) | 2003-02-25 | — | — | US | disclosed |
| US-20020099066-A1 | Antitumour 1,5-diazaanthraquinones | UNIVERSIDAD COMPLUTENSE DE MADRID (ES) | 2002-07-25 | — | — | US | disclosed |
| EP-1080090-A1 | ANTITUMOUR 1,5-DIAZAANTHRAQUINONES | UNIVERSIDAD COMPLUTENSE DE MADRID (ES) | 2001-03-07 | — | — | EP | disclosed |
| WO-1999059996-A1 | ANTITUMOUR 1,5-DIAZAANTHRAQUINONES | UNIVERSIDAD COMPLUTENSE DE MADRID (ES) | 1999-11-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020099066-A1 | Antitumour 1,5-diazaanthraquinones | PRMT7, TPD52L2, DRD4 | KMT2A 147/4885CCR1 2432/4885CCR5 3303/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.